Angela Hong

Clinical Professor Angela Hong is affiliated with the Department of Medicine at the Central Clinical School, University of Sydney. Her research focuses on radiation oncology, cancer treatment, and translational research, with a particular emphasis on melanoma, sarcoma, and neurotropic cancers. She leads multidisciplinary teams such as the SPARC program for retroperitoneal sarcoma and contributes to clinical trials evaluating radiation therapy, immunotherapy, and targeted therapies. Her work spans surgical oncology, adjuvant therapies, and quality-of-life outcomes in patients with brain metastases and high-risk melanoma. Professor Hong collaborates extensively with international groups on rare sarcomas and sarcoma center outcomes.

Key research interests include radiation therapy techniques for neurotropic melanoma, combined modality treatments (radiation + immunotherapy), and systemic reviews of sarcoma management. She has authored over 130 peer-reviewed publications, focusing on clinical trials, retrospective studies, and translational research in oncology.